ELUT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 40.80%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Elutia Insider Trading History Chart

Elutia Share Price & Price History

^$4.36

▼ -0.02 (-0.46%)

As of 11/21/2024 01:00 AM ET

Days: 30 | 90 | 365

Download Our Tesla Ebook For Free

From DTI | Ad

Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.

To claim your copy free of charge simply follow this link.

Elutia Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/27/2023	Birchview Capital, Lp	Major Shareholder	Buy	10,000	$1.59	$15,900.00	1,655,184
3/23/2023	Birchview Capital, Lp	Major Shareholder	Buy	110,000	$1.49	$163,900.00	1,625,184
3/9/2023	Thomas Englese	Insider	Sell	289	$4.30	$1,242.70	17,917
12/15/2022	David Colpman	Director	Buy	3,098	$3.90	$12,082.20	3,098
12/9/2022	Brigid Makes	Director	Buy	2,000	$3.65	$7,300.00	2,000
12/5/2022	Highcape Capital, L.P.	Director	Buy	735,000	$4.75	$3,491,250.00	5,597,604
12/5/2022	Matthew Ferguson	CFO	Buy	22,000	$4.65	$102,300.00	45,217
12/2/2022	Matthew Ferguson	CFO	Buy	6,000	$4.03	$24,180.00	23,217
12/14/2021	Thomas Englese	Insider	Buy	4,580	$6.10	$27,938.00
12/8/2021	Highcape Capital, L.P.	Director	Buy	412,735	$4.24	$1,749,996.40

Buffett Dumps $982 Million in BofA Stock—What Does He Know?

From Genesis Gold Group | Ad

Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.

Get your FREE, no-obligation Wealth Protection Guide now

SEC Filings (Institutional Ownership Changes) for Elutia (NASDAQ:ELUT)

74.03% of Elutia stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Elutia Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2024	Geode Capital Management LLC	188,408	$0.72M	0.0%	+50.3%	0.553%
11/5/2024	Arcus Capital Partners LLC	20,000	$76K	0.0%	+100.0%	0.059%
10/31/2024	Perkins Capital Management Inc.	856,552	$3.26M	3.0%	+9.8%	3.529%
8/20/2024	Nantahala Capital Management LLC	1,795,697	$8.91M	0.5%	+8.8%	7.398%
8/9/2024	Renaissance Technologies LLC	53,616	$0.27M	0.0%	+50.5%	0.221%
8/7/2024	AIGH Capital Management LLC	1,697,316	$8.42M	2.6%	+288.8%	6.993%
7/24/2024	Arcus Capital Partners LLC	10,000	$50K	0.0%	N/A	0.041%
5/10/2024	Perkins Capital Management Inc.	797,602	$2.51M	2.1%	N/A	3.286%
4/26/2024	Verdence Capital Advisors LLC	14,410	$45K	0.0%	N/A	0.059%
8/14/2023	Prosight Management LP	324,425	$0.77M	0.2%	+65.1%	1.998%
7/31/2023	Verdence Capital Advisors LLC	14,410	$34K	0.0%	N/A	0.089%
7/21/2023	Perkins Capital Management Inc.	348,948	$0.82M	0.7%	+26.7%	2.149%
5/12/2023	Prosight Management LP	196,443	$0.30M	0.1%	+6.2%	1.213%
5/9/2023	Perkins Capital Management Inc.	275,329	$0.42M	0.4%	+6.3%	1.701%
5/8/2023	Brown Advisory Inc.	32,887	$50K	0.0%	-85.7%	0.203%
2/15/2023	Endurant Capital Management LP	1,259,544	$5.35M	2.2%	+10.5%	9.147%
2/3/2023	Birchview Capital LP	1,515,184	$6.44M	4.5%	+6.8%	11.004%
1/26/2023	Perkins Capital Management Inc.	259,079	$1.10M	1.2%	+18.7%	1.881%
11/15/2022	Endurant Capital Management LP	1,139,932	$8.21M	2.7%	+0.6%	8.370%
10/24/2022	Perkins Capital Management Inc.	218,329	$1.57M	1.8%	-3.7%	1.603%
5/17/2022	Endurant Capital Management LP	1,109,479	$6.60M	1.7%	+3.1%	8.182%
5/13/2022	Platinum Investment Management Ltd.	188,181	$1.12M	0.0%	-3.9%	1.388%
11/9/2021	BlackRock Inc.	6,523	$45K	0.0%	-57.3%	0.064%
10/25/2021	Perkins Capital Management Inc.	228,425	$1.59M	1.0%	+47.9%	2.233%
8/27/2021	Endurant Capital Management LP	873,159	$8.39M	2.3%	+49.6%	8.536%
8/17/2021	Walleye Capital LLC	83,253	$0.80M	0.0%	+288.2%	0.814%
8/17/2021	Man Group plc	10,214	$98K	0.0%	-45.0%	0.100%
8/13/2021	AWM Investment Company Inc.	175,650	$1.69M	0.2%	+64.0%	1.717%
8/13/2021	Vanguard Group Inc.	55,261	$0.53M	0.0%	-14.5%	0.540%
8/12/2021	Ergoteles LLC	10,000	$96K	0.0%	N/A	0.098%
8/10/2021	Birchview Capital LP	30,000	$0.29M	0.2%	N/A	0.293%
8/9/2021	O Shaughnessy Asset Management LLC	2,871	$28K	0.0%	N/A	0.028%
5/18/2021	Millennium Management LLC	40,694	$0.56M	0.0%	-56.3%	0.398%
5/18/2021	Man Group plc	18,582	$0.26M	0.0%	N/A	0.182%
5/17/2021	Endurant Capital Management LP	583,600	$8.07M	2.1%	+43.0%	5.706%
5/17/2021	Walleye Capital LLC	21,445	$0.30M	0.0%	-78.7%	0.210%
5/13/2021	AWM Investment Company Inc.	107,077	$1.48M	0.2%	-58.4%	1.047%
5/13/2021	Platinum Investment Management Ltd.	141,395	$1.95M	0.0%	N/A	1.383%
5/12/2021	Northern Trust Corp	25,230	$0.35M	0.0%	+13.0%	0.247%
5/7/2021	BlackRock Inc.	46,953	$0.65M	0.0%	+53.2%	0.459%
3/26/2021	Susquehanna International Group LLP	13,679	$0.19M	0.0%	N/A	0.134%
2/19/2021	JPMorgan Chase & Co.	6,108	$83K	0.0%	N/A	0.060%
2/16/2021	Walleye Capital LLC	100,803	$1.37M	0.1%	N/A	0.986%
2/16/2021	Squarepoint Ops LLC	11,931	$0.16M	0.0%	N/A	0.117%
2/16/2021	Endurant Capital Management LP	408,213	$5.56M	2.0%	N/A	3.992%
2/12/2021	Caas Capital Management LP	10,000	$0.14M	0.0%	N/A	0.098%
2/12/2021	Laurion Capital Management LP	10,000	$0.14M	0.0%	N/A	0.098%
2/12/2021	AWM Investment Company Inc.	257,377	$3.51M	0.4%	N/A	2.517%
2/11/2021	Northern Trust Corp	22,337	$0.30M	0.0%	N/A	0.218%
2/9/2021	Perkins Capital Management Inc.	139,375	$1.90M	1.2%	N/A	1.363%
2/8/2021	New York State Common Retirement Fund	5,900	$80K	0.0%	N/A	0.058%
2/5/2021	BlackRock Inc.	30,644	$0.42M	0.0%	N/A	0.300%

Data available starting January 2016

Elutia Inc., a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators. The company also develops CanGarooRM, a combination of the CanGaroo envelope with antibiotics, to reduce the risk of infection after surgical implantation of an electronic device. In addition, it provides ProxiCor for cardiac tissue repair and pericardial closure; Tyke, an extracellular material that is used in the repair of cardiac structures for neonate and infant patients; and VasCure, a patch material to repair or reconstruct the peripheral vasculature. Further, the company offers SimpliDerm, which uses human acellular dermal matrices for tissue repair and reconstruction in various applications, such as sports medicine, hernia repair, trauma reconstruction, and breast reconstruction surgeries following mastectomy. It serves hospitals and healthcare facilities through its direct sales force, independent sales agents, and distributors. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland.

Today's Range

Now: $4.36

$4.04

$4.40

50 Day Range

MA: $3.73

$3.14

$4.38

52 Week Range

Now: $4.36

$1.63

$5.24

Volume

37,614 shs

Average Volume

41,773 shs

Market Capitalization

$148.50 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.76

Who are the company insiders with the largest holdings of Elutia?: Elutia's top insider investors include:
Highcape Capital, LP (Director)
Birchview Capital, Lp (Major Shareholder)
Matthew Ferguson (CFO)
Thomas Englese (Insider)
David Colpman (Director)
Brigid Makes (Director)
Learn More about top insider investors at Elutia.
Who are the major institutional investors of Elutia?: Elutia's top institutional shareholders include:
Perkins Capital Management Inc. — 3.53%
Geode Capital Management LLC — 0.55%
Arcus Capital Partners LLC — 0.06%
Learn More about top institutional investors of Elutia stock.
Which institutional investors are buying Elutia stock?: During the last quarter, ELUT stock was purchased by institutional investors including:
Perkins Capital Management Inc.
Geode Capital Management LLC
Arcus Capital Partners LLC
In the previous year, these company insiders have bought Elutia stock:
Highcape Capital, LP (Director)
Birchview Capital, Lp (Major Shareholder)
Matthew Ferguson (CFO)
Thomas Englese (Insider)
David Colpman (Director)
Learn More investors buying Elutia stock.